KSENIA VORONINA: Open Payments
NPI 1447694542 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 45 payments from 13 companies in 2025. Trend: 2023 $559 · 2024 $574 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 6 | $369 |
| Lundbeck LLC | 9 | $219 |
| Janssen Pharmaceuticals, Inc | 9 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Bausch Health US, LLC | 4 | $84 |
| Sage Therapeutics, LLC | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Tris Pharma Inc | 1 | $29 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, REXULTI, SPRAVATO, INGREZZA, APLENZIN, ZURZUVAE, Auvelity, CAPLYTA.
Industry payments across CA — which companies pay providers there.
